ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group
 

LOGIN



Please enter your username and password.


Username

Password


  
ANZMTG
Printer Friendly

Videos


ANZMTG 02.12 RADICAL Trial (2 September 2015)
 

This is a video of RADICAL trial. A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna (LM) when staged surgical excision with 5mm margins is not possible, is refused, or fails.

Return to top

ANZMTG 01.07 Whole Brain Radiotherapy in Melanoma Trial (17 April 2012)
 

This is a video for patients who have metastatic melanoma with deposits in their brain and for their family and friends. The video describes current treatment of melanoma brain metastases and has interviews with Australian clinicians.

Return to top

ANZMTG 01.12 EAGLE FM Trial - Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma  
 

This is a video demonstrating an open minimally invasive technique for pelvic lymph node dissection which is the recommended technique in this study.

ANZMTG 01.12 EAGLE FM Trial - Lymphoedema Assessments
 
We have produced an instructional video on the lymphoedema assessments performed in the EAGLE FM Study
 
 
 

Lymphoedema is the swelling of the tissues under the skin that may occur after lymph node surgery. It occurs when there is a breakdown or blockage in the Lymphatic drainage system resulting in some of the lymph fluid remaining in the tissues. The incidence of Lymphoedema following treatment varies with the extent of surgery performed and whether or not radiotherapy is used.

ANZMTG’s EAGLE FM Trial includes a sub-study to monitor the development of Lymphoedema in patients who have undergone Inguinal or Ilio-Inguinal Lymphadenectomies.

EAGLE FM patients are observed for any interventions they receive in response to their lymphoedema. Patients are also observed for a change in limb circumference and hip-flexor and calf length. Bio-impedance measurements are also taken (where available).

Patients are followed up with these Lymphoedema specific exams every 6 months for the first 2 years and then annually until they reach year 5 of follow up.

Return to top

Administering an NCF assessment (19 August 2012)

This 19-minute video shows a complete NCF assessment. After an introduction by the chief investigator, Dr. Gerald Fogarty, and a behavioural scientist, Dr. Haryana Dhillon, the video goes on to show how to properly administer all six assessments as well as how to handle a few common questions that might arise during the testing.

Return to top

Clare Oliver Anniversary - Melanoma survivor interviews - Jay Allen (19 September 2012)

On 13 September 2007, Clare Oliver lost her battle with skin cancer. Five years on, SunSmart Victoria spoke to melanoma survivors who are keeping her legacy alive.

Return to top

Melanoma: Winning the Battle (26 August 2012)

Medical oncologist, Dr Georgina Long, is speaking about the battle against melanoma and the future of treatment. This recording was done at the launch of the Melanoma Genome Project at Melanoma Institute Australia on 24th August 2012.

The Melanoma Genome Project is an ambitious and important two-year national research program that aims to identify the common gene mutations that lead to melanoma. The effort aims to identify new targets for effective treatments based on the genetic characteristics of individual melanomas.

For more information, visit www.melanoma.org.au.

Return to top